Provided are methods of detecting the presence or amount of a vitamin D metabolite in a sample using mass spectrometry. The methods generally comprise ionizing a vitamin D metabolite in a sample and detecting the amount of the ion to determine the presence or amount of the vitamin D metabolite in the sample. Also provided are methods to detect the presence or amount of two or more vitamin D metabolites in a single assay.
Claims That which is claimed is: 1. A method for determining the presence or amount of 25-hydroxyvitamin D.sub.3 in a sample by tandem mass spectrometry, comprising: (a) generating a protonated and dehydrated precursor ion of 25-hydroxyvitamin D.sub.3 with a mass to charge ratio (m/z) of 383.16.+-.0.5; (b) generating one or more fragment ions of said precursor ion; and (c) detecting the presence or amount of one or more of said ions generated in step (a) or (b) or both and relating the detected ions to the presence or amount of 25-hydroxyvitamin D.sub.3 in said sample. 2. The method of claim 1, wherein said sample is subjected to a purification step prior to ionization. 3. The method of claim 2, wherein said purification step comprises chromatography. 4. The method of claim 3, wherein said chromatography comprises high performance liquid chromatography (HPLC). 5. The method of claim 2, wherein said purification step comprises protein precipitation. 6. The method of claim 5, wherein said purification step does not include high turbulence liquid chromatography (HTLC). 7. The method of claim 2, wherein said purification step comprises chiral chromatography. 8. The method of claim 1, wherein said sample or 25-hydroxyvitamin D.sub.3 is not subjected to gas-chromatography prior to said ionization step. 9. The method of claim 1, wherein said one or more fragment ions comprise a fragment ion with an m/z of 211.35.+-.0.5. 10. The method of claim 1, 1,25-dihydroxyvitamin D.sub.2 in the sample. 11. A method for determining the presence or amount of two or more vitamin D metabolites in a sample in a single assay, said method comprising: (a) ionizing said two or more vitamin D metabolites, if present in said sample, to generate protonated and dehydrated precursor ions specific for each of said two or more vitamin D metabolites; (b) generating one or more fragment ions of each of said precursor ions; and (c) detecting the presence or amount of one or more of said ions generated in step (a) or (b) or both and relating the detected ions to the presence or amount of said two or more vitamin D metabolites in said sample; wherein said two or more vitamin D metabolites comprise 25-hydroxyvitamin D.sub.3 and 25-hydroxyvitamin D.sub.2; and wherein the precursor ion of 25-hydroxyvitamin D.sub.3 has a mass/charge ratio (m/z) of 383.16.+-.0.5 and the precursor ion of 25-hydroxyvitamin D.sub.2 has a mass/charge ratio (m/z) of 395.30.+-.0.5. 12. The method of claim 11, wherein said sample subjected to a purification step prior to said ionization step. 13. The method of claim 12, wherein said purification step comprises chromatography. 14. The method of claim 13, wherein said chromatography comprises high performance liquid chromatography (HPLC). 15. The method of claim 12, wherein said purification step comprises protein precipitation and does not include high turbulence liquid chromatography. 16. The method of claim 11, wherein said sample or said two or more vitamin D metabolites are not subjected to gas-chromatography prior to said ionization step. 17. The method of claim 11, wherein the one or more fragment ions for 25-hydroxyvitamin D.sub.3 comprise an ion with an m/z of 383.16.+-.0.5. 18. The method of claim 11, wherein the one or more fragment ions for 25-hydroxyvitamin D.sub.2 comprise one or more ions selected from the group consisting of ions with a m/z of 179.10.+-.0.5, 209.20.+-.0.5, and 251.30.+-.0.5. 19. The method of claim 11, wherein said two or more vitamin D metabolites further comprise one or more vitamin D metabolites selected from the group consisting of 1,25-dihydroxyvitamin D.sub.3 and 1,25-dihydroxyvitamin D.sub.2. 20. The method of claim 11, wherein said two or more vitamin D metabolites further comprise 1,25-dihydroxyvitamin D.sub.3 and 1,25-dihydroxyvitamin D.sub.2. 21. A method for determining the presence or amount of 25-hydroxyvitamin D.sub.2 in a sample by tandem mass spectrometry, comprising: (a) generating a protonated and dehydrated precursor ion of said 25-hydroxyvitamin D.sub.2 with a mass to charge ratio (m/z) of 395.30.+-.0.5; (b) generating one or more fragment ions of said precursor ion; and (c) detecting the presence or amount of one or more of said ions generated in step (a) or (b) or both and relating the detected ions to the presence or amount of said 25-hydroxyvitamin D.sub.2 in said sample. 22. The method of claim 21, wherein said sample is subjected to a purification step prior to ionization. 23. The method of claim 22, wherein said purification step comprises chromatography. 24. The method of claim 23, wherein said chromatography comprises high performance liquid chromatography (HPLC). 25. The method of claim 22, wherein said purification step comprises protein precipitation. 26. The method of claim 25, wherein said purification step does not include high turbulence liquid chromatography (HTLC). 27. The method of claim 22, wherein said purification step comprises chiral chromatography. 28. The method of claim 21, wherein said sample or said 25-hydroxyvitamin D.sub.2 is not subjected to gas-chromatography prior to said ionization step. 29. The method of claim 21, wherein said one or more fragment ions comprise one or more ions selected from the group consisting of ions with a m/z of 179.10.+-.0.5, 209.20.+-.0.5, and 251.30.+-.0.5. 30. The method of claim 29, wherein said one or more fragment ions comprise two or more ions selected from the group consisting of ions with a m/z of 179.10.+-.0.5, 209.20.+-.0.5, and 251.30.+-.0.5. 31. The method of claim 21, further comprising determining the presence or amount of 1,25-dihydroxyvitamin D.sub.2 in the sample. 